• Font Size:
  • Print

In a 13D filing after the close on Omnicare, Inc. (NYSE: OCR), ValueAct Capital disclosed a 6.5% stake (7,942,925 shares) in the company. This up from the 1,288,800 share stake the firm held at the quarter ended June 30, 2007.

In a pretty standard disclosure, the firm did not make any direct requests on the company, but said they will monitor their investment and may enter discussions with management, the Board of Directors or others.

The firm paid on average about $27 per share for the stock. The current stock price is $30.24.

Shares of OCR are near a 52-week low ($29.11)

Lon Juricic

About this author:
Become a Contributor Submit an Article

ETFs In Focus

  • Long Ideas

  • Short Ideas

  • Cramer's Picks